| scholarly article | Q13442814 |
| P50 | author | Sara Lindstroem | Q77022171 |
| Peter Kraft | Q77526208 | ||
| P2093 | author name string | J Kim | |
| C Kabrhel | |||
| L B Harrington | |||
| K Hagan | |||
| N Giordano | |||
| A Van Hylckama Vlieg | |||
| B A Parry | |||
| E M Poole | |||
| J A Lasky-Su | |||
| O A Zeleznik | |||
| P2860 | cites work | Processing methods for differential analysis of LC/MS profile data | Q24813623 |
| Identification of reduced circulating haptoglobin concentration as a biomarker of the severity of pulmonary embolism: a nontargeted proteomic study | Q28540157 | ||
| Proteomics of microparticles after experimental pulmonary embolism | Q29347018 | ||
| Acylcarnitines are anticoagulants that inhibit factor Xa and are reduced in venous thrombosis, based on metabolomics data | Q30980433 | ||
| Comparative proteome analysis of serum from acute pulmonary embolism rat model for biomarker discovery | Q33268201 | ||
| Comparative proteomic study of acute pulmonary embolism in a rat model | Q33289015 | ||
| The role of smoking in coagulation and thromboembolism in chronic obstructive pulmonary disease | Q36237005 | ||
| Electronic medical record review as a surrogate to telephone follow-up to establish outcome for diagnostic research studies in the emergency department | Q36258624 | ||
| False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies | Q38211946 | ||
| Whole-genome sequencing identifies common-to-rare variants associated with human blood metabolites | Q38927327 | ||
| Impact of Pulmonary Arterial Clot Location on Pulmonary Embolism Treatment and Outcomes (90 Days). | Q38983540 | ||
| Biological and clinical significance of haptoglobin polymorphism in humans | Q41150251 | ||
| Arachidonoylcholine and N,N-dimethylaminoethyl arachidonate are new cholinergic compounds | Q43667116 | ||
| Factors associated with clinical deterioration shortly after PE. | Q44998406 | ||
| Relation Among Clot Burden, Right-Sided Heart Strain, and Adverse Events After Acute Pulmonary Embolism | Q45045033 | ||
| Massive pulmonary embolism. | Q51283414 | ||
| Comparison of clinical scores for identification of patients with pulmonary embolism at intermediate-high risk of adverse clinical outcome: the prognostic role of plasma lactate. | Q51500685 | ||
| Reduction in plasma haptoglobin in humans with acute pulmonary embolism causing tricuspid regurgitation. | Q53346187 | ||
| Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model. | Q54405767 | ||
| Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: "the study of men born in 1913" | Q73009871 | ||
| Prognostic value of plasma lactate levels among patients with acute pulmonary embolism: the thrombo-embolism lactate outcome study | Q85888099 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 500-507 | |
| P577 | publication date | 2017-12-29 | |
| P1433 | published in | Journal of Thrombosis and Haemostasis | Q6296004 |
| P1476 | title | Metabolomic analysis of 92 pulmonary embolism patients from a nested case-control study identifies metabolites associated with adverse clinical outcomes | |
| P478 | volume | 16 |
| Q89719830 | Arachidonoylcholine and Other Unsaturated Long-Chain Acylcholines Are Endogenous Modulators of the Acetylcholine Signaling System |
| Q92783538 | Isolation of a Novel Metalloproteinase from Agkistrodon Venom and Its Antithrombotic Activity Analysis |
| Q64922604 | Metabolites Associated With the Risk of Incident Venous Thromboembolism: A Metabolomic Analysis. |
| Q92930741 | Metabolomics as a tool to improve decision making for the vascular surgeon - wishful thinking or a dream come true? |
| Q89941192 | Plasma metabolomic profile in chronic thromboembolic pulmonary hypertension |
Search more.